Patient-derived first generation xenografts of prostate cancers: promising tools for predicting drug responses for personalised chemotherapy
Proceedings article published in 2015 by
R. Beekharry,
Mll Labarthe-Last,
Simms,
Vm Mann,
Njm Maitland,
Ac Collins 
